Comparative analysis of trace element levels in disorders of sex development case and control groups: A detailed observational study

Abstract

Disorders of Sex Development (DSDs) refer to a group of congenital conditions characterized by atypical development of chromosomal, gonadal, or anatomical sex. This can result in variations in genitalia that do not fit typical definitions of male or female. This study examines trace element levels in patients with DSDs using Atomic Absorption Spectroscopy (AAS). The analysis focused on iron (Fe), copper (Cu), zinc (Zn), chromium (Cr), selenium (Se), and magnesium (Mg). The concentrations of these elements were compared between a group of DSD patients (case group) and a control group without DSDs. The results indicated a statistically significant difference in iron levels, with the DSD patients showing notably higher concentrations (p < 0.05) compared to the control group. In contrast, the levels of copper, zinc, chromium, selenium, and magnesium did not show significant differences between the two groups. The elevated iron levels in DSD patients suggest a potential alteration in iron metabolism associated with these disorders. This finding highlights the importance of further research to understand the role of iron in the etiology and management of DSDs. The lack of significant differences in the other trace elements, such as Cu, Zn, Cr, Se, and Mg, suggests that these elements might not be as critically involved in the pathophysiology of DSDs as iron. Nonetheless, the study underscores the necessity for a deeper exploration of trace element imbalances and their potential impacts on health outcomes in DSD patients. Further investigations could provide insights into whether these imbalances contribute to the development or progression of DSDs and how they might be addressed in clinical practice.